Cover Image
Market Research Report

Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) - Global Forecasts to 2024

Published by MarketsandMarkets Product code 863501
Published Content info 133 Pages
Delivery time: 1-2 business days
Price
Back to Top
Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) - Global Forecasts to 2024
Published: June 7, 2019 Content info: 133 Pages
Description

"The healthcare distribution market is projected to grow at a CAGR of 6.5% during the forecast period of 2019 to 2024"

The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024 from USD 765.4 billion in 2019, at a CAGR of 6.5%. The growth of this market is primarily driven by the rising incidence of chronic diseases, growing importance of generics, rising adoption of track & trace solutions, and the growth of the medical device industry. In addition, emerging markets such as China and India, growth in the biosimilars market, increasing specialty drug dispensing, and the rising uptake of biopharmaceuticals are expected to offer potential growth opportunities to market players in the coming years. However, increasing pricing pressure is a major challenge faced by market players.

Pharmaceutical product distribution services segment is expected to account for the largest share of the healthcare distribution market, by type, in 2018

Based on type, the healthcare distribution market is segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In 2018, the pharmaceutical product distribution services segment accounted for the largest share of this market owing to the increasing production of pharmaceutical formulations, rising pharmaceutical R&D expenditure, outsourcing of pharmaceutical manufacturing to Asian countries, and the establishment of new manufacturing facilitates by global pharmaceutical giants in newer geographies.

Retail pharmacies segment to dominate the healthcare distribution market, by end user, during the forecast period

The retail pharmacies segment accounted for the largest share of the market in 2018. These pharmacies deal with a large volume of prescriptions on a daily basis. Moreover, in the US and other developed countries, the implementation of programs to ensure affordable healthcare for citizens has significantly increased the volume of prescriptions in retail pharmacies.

APAC market to witness the highest growth during the forecast period

North America accounted for the largest share of the global healthcare distribution market in 2018, followed by Europe. However, the APAC market is estimated to grow at the highest CAGR during the forecast period. This can primarily be attributed to the growing regulatory requirements in the healthcare industries of several APAC countries to maintain compliance with good manufacturing and distribution practices and the rising number of pharmaceutical and biotechnology companies in the region. China and India are the fastest-growing markets in this region primarily due to the expanding pharmaceutical industries in these countries and the implementation of stringent regulations to enhance the quality and reliability of pharmaceutical drugs (as they move from manufacturing to the consumer).

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20%
  • By Designation: C-level - 43%, Director-level - 32%, and Others - 25%
  • By Region: North America - 38%, Europe - 29%, Asia Pacific - 23%, and the Rest of the World - 10%

The prominent players operating in this market are: McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US), Morris and Dickson Co., LLC (US), KeySource Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), Mutual Drug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), and CuraScript SD (US).

Research Coverage:

This report analyzes the healthcare distribution market and aims at estimating the size and future growth potential of this market as well as its segments. The report also includes an in-depth competitive analysis of the key players operating in this market, along with their company profiles, solution & service offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater market share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

  • Market Penetration: Comprehensive information on the solution/service portfolios offered by the top players in the healthcare distribution market
  • Solution & Service Development/Innovation: Detailed insights on the upcoming trends, and solution and service launches in the healthcare distribution market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new solutions and services, growing geographies, and recent developments in the global healthcare distribution market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and solution & service offerings of the leading players operating in the healthcare distribution market
Table of Contents
Product Code: PH 7149

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key Data from Secondary Sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key Data from Primary Sources
      • 2.1.2.2. Key Industry Insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HEALTHCARE DISTRIBUTION SERVICES: MARKET OVERVIEW
  • 4.2. NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE (2018)
  • 4.3. EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER (2018)
  • 4.4. HEALTHCARE DISTRIBUTION SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High incidence and large economic burden of chronic diseases
      • 5.2.1.2. Favorable R&D investment scenario and subsequent increase in drug launches
      • 5.2.1.3. Growth of track & trace solutions
      • 5.2.1.4. Growing importance of generics
      • 5.2.1.5. Growth of the medical devices industry
    • 5.2.2. OPPORTUNITIES
      • 5.2.2.1. Growth in the biosimilars market
      • 5.2.2.2. Emerging markets
      • 5.2.2.3. Increasing specialty drug dispensing
      • 5.2.2.4. Increasing uptake of biopharmaceuticals
    • 5.2.3. CHALLENGES
      • 5.2.3.1. Pricing pressures

6. HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES
    • 6.2.1. OVER-THE-COUNTER DRUGS/VITAMINS
      • 6.2.1.1. Sales of OTC drugs have risen due to innovations, promotion of self-medication, and increased access
    • 6.2.2. BRAND-NAME/INNOVATOR DRUGS
      • 6.2.2.1. Rising demand for prescription drugs to support the growth of this market segment
    • 6.2.3. GENERIC DRUGS
      • 6.2.3.1. Government initiatives for promoting the usage of generics to support the growth of this market segment
  • 6.3. MEDICAL DEVICE DISTRIBUTION SERVICES
  • 6.4. BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES
    • 6.4.1. MONOCLONAL ANTIBODIES
      • 6.4.1.1. Increasing incidence of cancer to support the growth of this market segment
    • 6.4.2. VACCINES
      • 6.4.2.1. Growing prevalence of infectious diseases has boosted vaccine development
    • 6.4.3. RECOMBINANT PROTEINS
      • 6.4.3.1. Growing applications of recombinant proteins in biopharmaceuticals to drive the growth of this market segment
    • 6.4.4. BLOOD AND BLOOD PRODUCTS
      • 6.4.4.1. Increasing number of blood donations and blood transfusions to support the growth of this market segment
    • 6.4.5. OTHER PRODUCTS

7. HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER

  • 7.1. INTRODUCTION
  • 7.2. RETAIL PHARMACIES
    • 7.2.1. LARGE VOLUME OF PRESCRIPTIONS TO INCREASE THE DEMAND FOR HEALTHCARE DISTRIBUTION SERVICES
  • 7.3. HOSPITAL PHARMACIES
    • 7.3.1. SIGNIFICANT NUMBER OF INPATIENT VISITS AND REQUIREMENT OF LARGE VOLUME OF DRUGS BY HOSPITALS TO DRIVE THE HEALTHCARE DISTRIBUTION SERVICES MARKET FOR HOSPITAL PHARMACIES
  • 7.4. OTHER END USERS

8. HEALTHCARE DISTRIBUTION SERVICES MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. US
      • 8.2.1.1. US dominates the North American healthcare distribution services market
    • 8.2.2. CANADA
      • 8.2.2.1. Rising prevalence of chronic diseases and increasing market for specialty drugs will drive market growth in Canada
  • 8.3. EUROPE
    • 8.3.1. GERMANY
      • 8.3.1.1. Germany accounted for the largest share of the European healthcare distribution services market in 2018
    • 8.3.2. FRANCE
      • 8.3.2.1. Presence of leading pharmaceutical companies in the country will drive market growth in France
    • 8.3.3. UK
      • 8.3.3.1. Growth in the pharmaceuticals market and increase in research activity will drive market growth in the UK
    • 8.3.4. REST OF EUROPE
  • 8.4. ASIA PACIFIC
    • 8.4.1. CHINA AND INDIA ARE THE FASTEST-GROWING MARKETS IN THE APAC
  • 8.5. REST OF THE WORLD

9. COMPETITIVE LANDSCAPE

  • 9.1. INTRODUCTION
  • 9.2. HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE ANALYSIS (2018)
  • 9.3. COMPETITIVE SCENARIO

10. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 10.1. MCKESSON CORPORATION
  • 10.2. CARDINAL HEALTH, INC.
  • 10.3. AMERISOURCEBERGEN CORPORATION
  • 10.4. OWENS & MINOR, INC.
  • 10.5. MORRIS & DICKSON CO. L.L.C.
  • 10.6. CURASCRIPT SPECIALTY DISTRIBUTION
  • 10.7. FFF ENTERPRISES, INC.
  • 10.8. MEDLINE INDUSTRIES
  • 10.9. ATTAIN MED, INC.
  • 10.10. DAKOTA DRUG

*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. DISCUSSION GUIDE: HEALTHCARE DISTRIBUTION SERVICES MARKET
  • 11.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3. AVAILABLE CUSTOMIZATIONS
  • 11.4. RELATED REPORTS
  • 11.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: SERIALIZATION & AGGREGATION REGULATIONS, BY COUNTRY/REGION
  • TABLE 2: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 3: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 4: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 5: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR OTC DRUGS/VITAMINS, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 6: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR BRAND-NAME/INNOVATOR DRUGS, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 7: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR GENERIC DRUGS, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 8: MEDICAL DEVICE DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 9: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 10: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 11: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 12: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR VACCINES, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 13: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR RECOMBINANT PROTEINS, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 14: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR BLOOD AND BLOOD PRODUCTS, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 15: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 16: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 17: HEALTHCARE DISTRIBUTION SERVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 18: HEALTHCARE DISTRIBUTION SERVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 19: HEALTHCARE DISTRIBUTION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 20: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 21: NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 22: NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 23: NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 24: NORTH AMERICA: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 25: NORTH AMERICA: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 26: US: PHARMACEUTICAL IMPORTS AND EXPORTS (2015)
  • TABLE 27: US: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 28: US: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 29: US: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 30: US: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 31: CANADA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 32: CANADA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 33: CANADA: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 34: CANADA: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 35: EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 36: EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 37: EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 38: EUROPE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 39: EUROPE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 40: GERMANY: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 41: GERMANY: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 42: GERMANY: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 43: GERMANY: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 44: FRANCE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 45: FRANCE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 46: FRANCE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 47: FRANCE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 48: UK: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 49: UK: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 50: UK: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 51: UK: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 52: ROE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 53: ROE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 54: ROE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 55: ROE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 56: ASIA PACIFIC: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 57: ASIA PACIFIC: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 58: ASIA PACIFIC: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 59: ASIA PACIFIC: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 60: ROW: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017-2024 (USD BILLION)
  • TABLE 61: ROW: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 62: ROW: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 63: ROW: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 64: SOLUTION AND SERVICE LAUNCHES, 2016-2019
  • TABLE 65: AGREEMENTS, COLLABORATIONS, AND CONTRACTS, 2016-2019
  • TABLE 66: ACQUISITIONS, 2016-2019
  • TABLE 67: EXPANSIONS, 2016-2019

LIST OF FIGURES

  • FIGURE 1: HEALTHCARE DISTRIBUTION SERVICES MARKET SEGMENTATION
  • FIGURE 2: HEALTHCARE DISTRIBUTION SERVICES MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE, BY TYPE, 2018
  • FIGURE 7: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET SHARE, BY TYPE, 2018
  • FIGURE 8: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET SHARE, BY TYPE, 2018
  • FIGURE 9: HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE, BY END USER, 2018
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE HEALTHCARE DISTRIBUTION SERVICES MARKET
  • FIGURE 11: RISING INCIDENCE OF CHRONIC DISEASES AND AVAILABILITY OF R&D INVESTMENTS ARE THE KEY FACTORS DRIVING MARKET GROWTH
  • FIGURE 12: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES SEGMENT DOMINATED THE NORTH AMERICAN HEALTHCARE DISTRIBUTION SERVICES MARKET IN 2018
  • FIGURE 13: RETAIL PHARMACIES ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN HEALTHCARE DISTRIBUTION SERVICES MARKET IN 2018
  • FIGURE 14: ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION)
  • FIGURE 16: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 17: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2019 VS. 2024 (USD BILLION)
  • FIGURE 18: HEALTHCARE DISTRIBUTION SERVICES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 19: NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET SNAPSHOT
  • FIGURE 20: EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET SNAPSHOT
  • FIGURE 21: Y-O-Y GROWTH IN THE GERMAN PHARMACEUTICAL INDUSTRY, 2011-2015
  • FIGURE 22: ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 23: ROW: MARKET SNAPSHOT
  • FIGURE 24: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 25: MCKESSON CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 26: CARDINAL HEALTH: COMPANY SNAPSHOT (2018)
  • FIGURE 27: AMERISOURCEBERGEN CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 28: OWENS & MINOR: COMPANY SNAPSHOT (2017)
Back to Top